Publications by authors named "R Katari"
Article Synopsis
- Chronic kidney diseases like end stage renal disease (ESRD) are getting worse and are a big health problem worldwide.
- Current treatments don’t really help stop the disease from getting worse, which is why scientists are looking into regenerative medicine, a way to repair or grow new kidneys.
- One promising technique called cell-on-scaffold seeding technology (CSST) places living cells on special materials to help fix damaged kidneys, and researchers are exploring how this could help people with kidney problems.
Tissue engineering (TE) offers a potential solution for the shortage of transplantable organs and the need for novel methods of tissue repair. Methods of TE have advanced significantly in recent years, but there are challenges to using engineered tissues and organs including but not limited to: biocompatibility, immunogenicity, biodegradation, and toxicity. Analysis of biomaterials used as scaffolds may, however, elucidate how TE can be enhanced.
View Article and Find Full Text PDFBackground: Mammalian target of rapamycin inhibitors have been used along with corticosteroids and/or induction therapy immediately after liver transplantation. Our aim was to assess the safety and tolerability of everolimus ab initio after liver transplantation without corticosteroids or induction, as well as efficacy in terms of liver function, rejection and graft loss.
Methods: A retrospective observational study of 50 adult patients (86% males, median age 54 years, range 25-68) who were liver transplanted between 2009 and 2013 and followed for 12 months.